Note: Ingredients listed on restricted chemical lists
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
*
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
*
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
*
General Information
Revision date
2025-12-01
Product name
Oxaprozin Capsules 300mg
Icons in SDS
Company Information
company name
SOLA Pharmaceuticals
e-mail address of the competent person responsible for the Safety Data Sheet
info@solameds.us
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Appearance: White capsule
Signal word
WARNING
Hazard statements
May cause gastrointestinal system effects
Additional information
Short Term: May cause mild eye irritation. May cause slight skin irritation. (based on components) . Accidental ingestion may cause effects similar to those seen in clinical use. Known Clinical Effects: Ingestion of this material may cause effects similar to those seen in clinical use including serious gastrointestinal toxicity such as bleeding, ulceration, and perforation and kidney toxicity. Individuals sensitive to this material or other materials in its chemical class may develop allergic reactions. Clinical use has resulted in liver effects. Symptoms may include jaundice, liver function test abnormalities, and hepatitis. Other nonsteroidal anti-inflammatory drugs (NSAIDs) are known to impact delivery, late fetal development, and lactation. EU Indication of danger: Dangerous for the Environment EU Hazard Symbols: EU Risk Phrases: R51/53 - Toxic to aquatic organisms. May cause long-term adverse effects in the aquatic environment.
